Phone: 1.510.856.5600|info@anthera.com

Investor Relations

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

NASDAQ: ANTH
0.60
- 0.01 (-1.73%)
4:00 PM ET on Jan 20, 2017
Delayed at least 20 minutes.
Day High 0.65
Day Low 0.59
52-Week High 4.90
Volume 699,641
Print Friendly